Correlation Between AptaBio Therapeutics and Heerim Architects

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Heerim Architects at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Heerim Architects into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Heerim Architects Planners, you can compare the effects of market volatilities on AptaBio Therapeutics and Heerim Architects and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Heerim Architects. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Heerim Architects.

Diversification Opportunities for AptaBio Therapeutics and Heerim Architects

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between AptaBio and Heerim is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Heerim Architects Planners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heerim Architects and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Heerim Architects. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heerim Architects has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Heerim Architects go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Heerim Architects

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to generate 1.1 times more return on investment than Heerim Architects. However, AptaBio Therapeutics is 1.1 times more volatile than Heerim Architects Planners. It trades about 0.0 of its potential returns per unit of risk. Heerim Architects Planners is currently generating about -0.01 per unit of risk. If you would invest  907,000  in AptaBio Therapeutics on September 12, 2024 and sell it today you would lose (293,000) from holding AptaBio Therapeutics or give up 32.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.71%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Heerim Architects Planners

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Heerim Architects 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Heerim Architects Planners has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Heerim Architects is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

AptaBio Therapeutics and Heerim Architects Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Heerim Architects

The main advantage of trading using opposite AptaBio Therapeutics and Heerim Architects positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Heerim Architects can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heerim Architects will offset losses from the drop in Heerim Architects' long position.
The idea behind AptaBio Therapeutics and Heerim Architects Planners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated